Bone is among the most common sites of metastasis in cancer patients, so it is an urgent need to develop drug delivery systems targeting tumor bone metastasis with the feature of controlled release. This study aimed to delivery of thermosensitive liposomal doxorubicin to bone for tumor metastasis treatment. First, Brij78 (polyoxyethylene stearyl ether) was conjugated with Pamidronate (Pa). By incorporating Pa-Brij78 to DPPC/Chol liposomes, we developed Pa surface functionalized liposomes. The Pa-Brij78/DPPC/Chol liposomes (PB-liposomes) exhibited a stronger binding affinity to hydroxyapatite (HA), a major component of bone, than Brij78/DPPC/Chol liposomes (B-liposomes). Doxorubicin (Dox) was then encapsulated in PB-liposomes and the results demonstrated complete release of Dox from PB-liposomes or the complex of HA/PB-liposomes within 10 min at 42 °C. Next, human lung cancer A549 cells were treated with the thermosensitive complex of HA/PB-liposomes/Dox to mimic tumor bone metastasis treatment through bone targeted delivery of therapeutic agents. Pre-incubation of HA/PB-liposomes/Dox with mild heat at 42 °C induced subsequent higher cytotoxicity to A549 cells than incubation of the same complex at 37 °C, suggesting more active drug release triggered by heat. In conclusion, we synthesized a novel surfactant Pa-Brij78 and it has the potential to be used for development of a bone targeted thermosensitive liposome formulation for treatment of tumor bone metastasis.
The purpose of the study was to develop a facile method for the fabrication of a stable and reusable magnetic graphene composite absorbent to remove trace levels of polybrominated diphenyl ethers in water treatment. The poly cationic Fe3O4@PDDA (poly(diallyldimethyl ammonium chloride) (PDDA)) core-shell structured nanoparticles were first synthesized, and then, DNA was laid on the surface of graphene oxide (GOx) to prepare the polyanionic GOx@DNA composite. The above materials were then mixed together and adhered together through sol-gel technology. Thus, the Fe3O4@PDDA/GOx@DNA composite absorbent was prepared. Its performance was tested by disperse solid phase extraction and gas chromatography/mass spectrometric (GC/MS) for removing six kinds of indicative polybrominated diphenyl ethers (BDEs) in water samples. The removal percentages of several real samples for six kinds of BDEs (BDE17, BDE28, BDE 71, BDE 47, BDE 66, BDE 100) at the ng/mL order of magnitude were in the range of 88.2%–99.1%. The removal percentage still reached 80.0% when the adsorbent was reused at least 20 times. The results suggested that the magnetic absorbent can obviously remove trace levels of BDEs from large volumes of aqueous solutions in environmental pollution cleanup with high removal efficiency.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.